Literature DB >> 8122571

Percentage of graft viability versus injected volume in adipose autotransplants.

C A Carpaneda, M T Ribeiro.   

Abstract

An adipose tissue graft's ability to obtain nutrition through plasmatic imbibition occurs approximately 1.5 mm from the vascularized edge. This and the observation that only 40% of this peripheral margin is viable led the authors to create spherical and cylindroid models to correlate the volume and the percentage of graft viability to the initial injected volume in adipose autotransplants. The authors concluded that the percentage of graft viability depends on the thickness and the geometrical shape and is inversely proportional to the graft diameter if grafts with a diameter greater than 3 mm are considered.

Entities:  

Mesh:

Year:  1994        PMID: 8122571     DOI: 10.1007/bf00444242

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  4 in total

1.  Transplantation of purified autologous fat: a 3-year follow-up is disappointing.

Authors:  R A Ersek
Journal:  Plast Reconstr Surg       Date:  1991-02       Impact factor: 4.730

2.  Present results of fat injection.

Authors:  Y G Illouz
Journal:  Aesthetic Plast Surg       Date:  1988-08       Impact factor: 2.326

3.  Fat-grafting injection for soft-tissue augmentation.

Authors:  A Chajchir; I Benzaquen
Journal:  Plast Reconstr Surg       Date:  1989-12       Impact factor: 4.730

4.  Study of the histologic alterations and viability of the adipose graft in humans.

Authors:  C A Carpaneda; M T Ribeiro
Journal:  Aesthetic Plast Surg       Date:  1993       Impact factor: 2.326

  4 in total
  26 in total

1.  Study of aspirated adipose tissue.

Authors:  C A Carpaneda
Journal:  Aesthetic Plast Surg       Date:  1996 Sep-Oct       Impact factor: 2.326

Review 2.  The use of fat grafting and platelet-rich plasma for wound healing: A review of the current evidence.

Authors:  Oliver J Smith; Gavin Jell; Ash Mosahebi
Journal:  Int Wound J       Date:  2018-11-20       Impact factor: 3.315

3.  Autologous fat transplantation for secondary breast reconstruction: our experience.

Authors:  F Simonacci; M P Grieco; N Bertozzi; E Raposio
Journal:  G Chir       Date:  2017 May-Jun

4.  Dll4 Inhibition Promotes Graft Retention in Fat Grafting Enriched with Adipose-Derived Stem Cells.

Authors:  Choong-Kun Lee; Bo-Yoon Park; Taehee Jo; Cheol-Heum Park; Ju-Hee Kim; Kyu-Jin Chung; Yong-Ha Kim; Do Young Park; Il-Kug Kim
Journal:  Stem Cells Transl Med       Date:  2022-07-20       Impact factor: 7.655

5.  Fat grafting of the buttocks and lower limbs.

Authors:  L H Pereira; H N Radwanski
Journal:  Aesthetic Plast Surg       Date:  1996 Sep-Oct       Impact factor: 2.326

6.  Cell-Based Soft Tissue Reconstruction in a Hydrogel Scaffold.

Authors:  Charles P Blackshear; John S Flacco; Stephanie M Vistnes; Natalie N Chung; Dre Irizarry; Elizabeth A Brett; Derek J Yen; Arash Momeni; Michael T Longaker; Derrick C Wan
Journal:  Ann Plast Surg       Date:  2017-12       Impact factor: 1.539

7.  Diffusion and perfusion: the keys to fat grafting.

Authors:  Roger K Khouri; Raoul-Emil R Khouri; Jorge R Lujan-Hernandez; Khalil R Khouri; Luca Lancerotto; Dennis P Orgill
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-10-07

8.  Application of microautologous fat transplantation in the correction of sunken upper eyelid.

Authors:  Tsai-Ming Lin; Tsung-Ying Lin; Chih-Kang Chou; Chung-Sheng Lai; Sin-Daw Lin
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-12-05

9.  Buccal Fat Pad for Interpositional Arthroplasty in Temporomandibular Joint Ankylosis.

Authors:  Adebayo A Ibikunle; Olutayo James; Wasiu L Adeyemo
Journal:  J Maxillofac Oral Surg       Date:  2018-06-04

10.  Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells.

Authors:  Kotaro Yoshimura; Katsujiro Sato; Noriyuki Aoi; Masakazu Kurita; Toshitsugu Hirohi; Kiyonori Harii
Journal:  Aesthetic Plast Surg       Date:  2007-09-01       Impact factor: 2.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.